Trial intelligence / Profile preview

Liraglutide effects on gastrointestinal physiology and food intake in healthy volunteers

2024-518641-21-00Phase 4Completed

Sponsor
UZ Leuven
Start
Feb 2020
Modality
Peptides
Countries
1
01

Overview

Phase 4 trial of liraglutide and saline in obesity (2 arms), sponsored by UZ Leuven. Primary endpoint: Change in migrating motor complex activity. Started Feb 2020; status: completed.

02

Drugs

03

Conditions

obesity

Beyond the preview

Go deeper on 2024-518641-21-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-518641-21-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call